p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1186/s12964-023-01337-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
- (2023) Alvar Agustí et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lung Imaging in COPD Part 1
- (2023) Suhail Raoof et al. CHEST
- Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?
- (2023) Yohannes Tesfaigzi et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A patent review of MAPK inhibitors (2018 – present)
- (2023) Valentin R Wydra et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Secreted phospholipase A2 XIIA triggers a mitochondrial damage-induced senescence in chronic obstructive pulmonary disease fibroblasts
- (2023) Danushki Herath et al. FREE RADICAL BIOLOGY AND MEDICINE
- When GETomics meets aging and exercise in COPD
- (2023) D. Pellegrino et al. RESPIRATORY MEDICINE
- Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan
- (2022) Alvar Agustí et al. Lancet Respiratory Medicine
- Unique characteristics of lung resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling
- (2022) Geon Ho Bae et al. BLOOD
- Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)
- (2022) Paolo Spagnolo et al. CURRENT OPINION IN PULMONARY MEDICINE
- Angiopoietin-like 4 knockdown attenuates cigarette smoke extract–induced oxidative stress and apoptosis in lung bronchial epithelial cells by inhibiting NADPH oxidase
- (2022) Hong Liu et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Oxidative stress causes muscle structural alterations via p38 MAPK signaling in COPD mouse model
- (2022) Yosuke Mano et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
- (2022) Haichuan Yu et al. Frontiers in Pharmacology
- Airway Smooth Muscle Cell Mitochondria Damage and Mitophagy in COPD via ERK1/2 MAPK
- (2022) Lei Fang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GOLD COPD report: 2023 update
- (2022) Priya Venkatesan Lancet Respiratory Medicine
- Inhibition of miR-494-3p alleviates oxidative stress-induced cell senescence and inflammation in the primary epithelial cells of COPD patients
- (2021) Qinghua Zeng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mesenchymal–Epithelial Transition in Fibroblasts of Human Normal Lungs and Interstitial Lung Diseases
- (2021) Carina Becerril et al. Biomolecules
- Overexpression of FOXA2 attenuates cigarette smoke-induced cellular senescence and lung inflammation through inhibition of the p38 and Erk1/2 MAPK pathways
- (2021) Yixiu Tao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- NOX4-Derived ROS Promotes Collagen I Deposition in Bronchial Smooth Muscle Cells by Activating Noncanonical p38MAPK/Akt-Mediated TGF-β Signaling
- (2021) Binwei Hao et al. Oxidative Medicine and Cellular Longevity
- Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies
- (2021) Corrado Pelaia et al. Drug Design Development and Therapy
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Lung Marginated and Splenic Murine Resident Neutrophils Constitute Pioneers in Tissue-Defense During Systemic E. coli Challenge
- (2021) Goda Juzenaite et al. Frontiers in Immunology
- Neutrophils Modulate Fibrogenesis in Chronic Pulmonary Diseases
- (2021) Lili Ding et al. Frontiers in Medicine
- The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
- (2021) Lanlan Zhu et al. MOLECULAR MEDICINE
- Cigarette smoke extracts induce apoptosis in Raw264.7 cells via endoplasmic reticulum stress and the intracellular Ca2+/P38/STAT1 pathway
- (2021) Haoshen Feng et al. TOXICOLOGY IN VITRO
- Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation
- (2021) Andreea C. Mihaila et al. Frontiers in Immunology
- p38 MAPKs — roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets
- (2021) Christopher M. Brennan et al. JCI Insight
- Diversity of Macrophages in Lung Homeostasis and Diseases
- (2021) Fei Hou et al. Frontiers in Immunology
- Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives
- (2020) Corrado Pelaia et al. Expert Review of Respiratory Medicine
- The p38 Pathway: From Biology to Cancer Therapy
- (2020) Adrián Martínez-Limón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro
- (2020) Mareike Ohms et al. Frontiers in Immunology
- TLR3 inhibitor and tyrosine kinase inhibitor attenuate cigarette smoke/poly I:C-induced airway inflammation and remodeling by the EGFR/TLR3/MAPK signaling pathway
- (2020) Jing-jin Jiang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Functions of p38 MAP Kinases in the Central Nervous System
- (2020) Prita R. Asih et al. Frontiers in Molecular Neuroscience
- Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies
- (2020) Lena Claesson-Welsh et al. TRENDS IN MOLECULAR MEDICINE
- CD147 increases mucus secretion induced by cigarette smoke in COPD
- (2019) Qiao Yu et al. BMC Pulmonary Medicine
- Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
- (2019) Peter J Barnes et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- MMP-12 regulates proliferation of mouse macrophages via the ERK/P38 MAPK pathways during inflammation
- (2019) Chenyu Guan et al. EXPERIMENTAL CELL RESEARCH
- Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD
- (2019) Irina R. Strâmbu et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD
- (2019) Jürgen Knobloch et al. Journal of Clinical Medicine
- Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
- (2019) Maria Teresa Masucci et al. Frontiers in Oncology
- Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis
- (2018) Neeraj Vij et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
- (2018) Marie Fisk et al. PLoS One
- Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
- (2018) Chun-Yu Lo et al. International Journal of Chronic Obstructive Pulmonary Disease
- Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells
- (2018) Andrew Higham et al. International Journal of Chronic Obstructive Pulmonary Disease
- The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
- (2018) Naimish Patel et al. International Journal of Chronic Obstructive Pulmonary Disease
- Pro-inflammatory effects of extracellular Hsp70 and cigarette smoke in primary airway epithelial cells from COPD patients
- (2018) Andrea Hulina-Tomašković et al. BIOCHIMIE
- MicroRNA-570 is a novel regulator of cellular senescence and inflammaging
- (2018) Jonathan R. Baker et al. FASEB JOURNAL
- What is Early COPD and Why is it Important?
- (2018) Joan B. Soriano et al. EUROPEAN RESPIRATORY JOURNAL
- Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
- (2018) Fabrizia Mariotti et al. International Journal of Chronic Obstructive Pulmonary Disease
- Metabolic re-patterning in COPD airway smooth muscle cells
- (2017) Charalambos Michaeloudes et al. EUROPEAN RESPIRATORY JOURNAL
- RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation
- (2017) Catherine E. Charron et al. EUROPEAN RESPIRATORY JOURNAL
- Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
- (2017) Steven Pascoe et al. RESPIRATORY MEDICINE
- Lung Pericytes and Resident Fibroblasts
- (2016) Luke Barron et al. AMERICAN JOURNAL OF PATHOLOGY
- The older the faster: aged neutrophils in inflammation
- (2016) E. Kolaczkowska BLOOD
- Aged neutrophils contribute to the first line of defense in the acute inflammatory response
- (2016) B. Uhl et al. BLOOD
- TLR4 Overexpression Inhibits Endothelial PAS Domain-Containing Protein 1 Expression in the Lower Respiratory Tract of Patients with Chronic COPD
- (2016) Hong Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- In vitro modeling of COPD inflammation and limitation of p38 inhibitor — SB203580
- (2016) Aihong Meng et al. International Journal of Chronic Obstructive Pulmonary Disease
- Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD
- (2016) Martin A. Bewley et al. PLoS One
- Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease
- (2015) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes
- (2015) Peter J. Barnes JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Neutrophils support lung colonization of metastasis-initiating breast cancer cells
- (2015) Stefanie K. Wculek et al. NATURE
- Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
- (2015) Peter Lange et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phospho-p38 MAPK Expression in COPD Patients and Asthmatics and in Challenged Bronchial Epithelium
- (2015) Davide Vallese et al. RESPIRATION
- Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?
- (2015) Wei Gao et al. RESPIROLOGY
- Pulmonary macrophages: key players in the innate defence of the airways
- (2015) Adam J Byrne et al. THORAX
- Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways
- (2015) Wen Gu et al. Scientific Reports
- Chronic obstructive pulmonary disease
- (2015) Peter J. Barnes et al. Nature Reviews Disease Primers
- Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
- (2014) Marie Fisk et al. American Journal of Cardiovascular Drugs
- Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice
- (2014) Hongxu Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- C-reactive protein and lung diseases
- (2014) Marianna Agassandian et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- p38 Mitogen-activated protein kinase accelerates emphysema in mouse model of chronic obstructive pulmonary disease
- (2014) Hiroyuki Amano et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses
- (2014) Yanyan Yang et al. MEDIATORS OF INFLAMMATION
- p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice
- (2014) Satoshi Marumo et al. BMC Pulmonary Medicine
- Synergy of IL-27 and TNF-α in Regulating CXCL10 Expression in Lung Fibroblasts
- (2013) Shanshan Dong et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- MLK3 is a direct target of biochanin A, which plays a role in solar UV-induced COX-2 expression in human keratinocytes
- (2013) Tae-Gyu Lim et al. BIOCHEMICAL PHARMACOLOGY
- Oxidative Stress in COPD
- (2013) Paul A. Kirkham et al. CHEST
- Regulation of Wnt4 in chronic obstructive pulmonary disease
- (2013) Andrew L. Durham et al. FASEB JOURNAL
- Cigarette smoke extract induces the expression of GRP78 in A549 cells via the p38/MAPK pathway
- (2013) BAIMEI HE et al. Molecular Medicine Reports
- P38 inhibition in COPD; cautious optimism
- (2013) Dave Singh THORAX
- Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells
- (2013) Irene Heijink et al. THORAX
- Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
- (2013) William MacNee et al. THORAX
- Lessons from ECLIPSE: a review of COPD biomarkers
- (2013) Rosa Faner et al. THORAX
- Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema
- (2013) Marco Chilosi et al. Translational Research
- Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV1 in COPD patients
- (2013) Hui Gao MEDICAL SCIENCE MONITOR
- Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
- (2013) Henrik Watz et al. Lancet Respiratory Medicine
- Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): Rationale and protocol
- (2013) M. Fisk et al. Artery Research
- IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation
- (2012) T Southworth et al. BRITISH JOURNAL OF PHARMACOLOGY
- p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD
- (2012) Audreesh Banerjee et al. CURRENT OPINION IN PHARMACOLOGY
- Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
- (2012) Kate Gaffey et al. EUROPEAN RESPIRATORY JOURNAL
- T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
- (2012) Manminder Kaur et al. RESPIRATORY RESEARCH
- Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages
- (2012) Marianne Jennifer Ratcliffe et al. BMC Pharmacology & Toxicology
- Telomere Dysfunction Causes Sustained Inflammation in Chronic Obstructive Pulmonary Disease
- (2011) Valerie Amsellem et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Behavioral and Structural Differences in Migrating Peripheral Neutrophils from Patients with Chronic Obstructive Pulmonary Disease
- (2011) Elizabeth Sapey et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD
- (2011) Kian Fan Chung CHEST
- p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011)
- (2011) Stefan Fischer et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?
- (2011) David S Millan Future Medicinal Chemistry
- Reduced glucocorticoid receptor expression and function in airway neutrophils
- (2011) Jonathan Plumb et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease
- (2011) David A. Lomas et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Synergistic Effects of p38 Mitogen-Activated Protein Kinase Inhibition with a Corticosteroid in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
- (2011) J. Armstrong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stress
- (2010) Min Kyoung Jang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway
- (2010) Yanling Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Resveratrol Impairs the Release of Steroid-Resistant Inflammatory Cytokines from Human Airway Smooth Muscle Cells in Chronic Obstructive Pulmonary Disease
- (2010) J. Knobloch et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Neutrophil kinetics in health and disease
- (2010) Charlotte Summers et al. TRENDS IN IMMUNOLOGY
- The Cytokine Network in Chronic Obstructive Pulmonary Disease
- (2009) Peter J. Barnes AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients
- (2009) Dave Singh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- TNF -induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism
- (2009) J Knobloch et al. THORAX
- Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice
- (2008) Hongwei Yao et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Molecular Mechanisms of Corticosteroid Resistance
- (2008) Ian M. Adcock et al. CHEST
- IN VITRO MODELING OF HUMAN ALVEOLAR MACROPHAGE SMOKE EXPOSURE: ENHANCED INFLAMMATION AND IMPAIRED FUNCTION
- (2008) Aaron R. Winkler et al. EXPERIMENTAL LUNG RESEARCH
- Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases
- (2008) Puneet Chopra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling
- (2008) Richard Leigh et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
- (2008) L. M. Kent et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Telomere shortening in chronic obstructive pulmonary disease
- (2008) Joyce M.J. Houben et al. RESPIRATORY MEDICINE
- Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase
- (2008) Shinichi HAYASHI et al. RESPIROLOGY
- Review: Antioxidant therapeutic advances in COPD
- (2008) Irfan Rahman Therapeutic Advances in Respiratory Disease
- β-Tryptase Regulates IL-8 Expression in Airway Smooth Muscle Cells by a PAR-2–Independent Mechanism
- (2007) Charlotte S. Mullan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Increased activation of p38 MAPK in COPD
- (2007) T. Renda et al. EUROPEAN RESPIRATORY JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started